Terdiman J P
Department of Medicine, University of California, San Francisco, USA.
Semin Gastrointest Dis. 1997 Oct;8(4):166-78.
Gastrointestinal hemorrhage in the patient with liver disease is often massive and life threatening. Although varices are the most likely cause of hemorrhage, other sources, such as peptic ulcer disease, Mallory-Weiss tears, and portal hypertensive gastropathy, are common. As liver disease is an important risk factor for intractable bleeding and death in patients with gastrointestinal hemorrhage, outcome in these patients is often poor regardless of the cause of the bleeding. Essential elements of initial therapy include prompt and adequate intravascular volume replacement, correction of severe anemia and coagulopathies, and adequate airway management. After initial resuscitation, urgent endoscopy is required to secure the diagnosis and to deliver endoscopic therapy if possible. The specific form of therapy will differ depending on the lesion encountered. Adjunctive measures, such as the administration of antibiotics and drugs that reduce portal pressure, including octreotide, may also improve outcome. Clinical and endoscopic information can be used to predict first bleeding in patients with liver disease. A large body of data supports the use of beta-blockers in the prevention of first bleeding in patients with known varices.
肝病患者的胃肠道出血通常出血量很大且危及生命。虽然静脉曲张是最可能的出血原因,但其他来源,如消化性溃疡病、马-魏二氏撕裂症和门静脉高压性胃病也很常见。由于肝病是胃肠道出血患者难治性出血和死亡的重要危险因素,无论出血原因如何,这些患者的预后通常都很差。初始治疗的基本要素包括迅速且充分地补充血管内容量、纠正严重贫血和凝血障碍,以及进行充分的气道管理。初始复苏后,需要紧急进行内镜检查以明确诊断,并尽可能进行内镜治疗。具体的治疗形式将根据所遇到的病变而有所不同。辅助措施,如使用抗生素和降低门静脉压力的药物(包括奥曲肽),也可能改善预后。临床和内镜检查信息可用于预测肝病患者的首次出血。大量数据支持使用β受体阻滞剂预防已知有静脉曲张患者的首次出血。